Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 34 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

34 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 13, 2025 VOR S 10b5-1 2,227 $1.42 $3,162 126,625 Direct -1.73% Disposed -34.6% (price as of 2026-10-05)
Feb. 10, 2025 VOR S 10b5-1 2,554 $1.37 $3,499 128,852 Direct -1.94% Disposed -32.2% (price as of 2026-10-05)
Dec. 27, 2024 VOR S 10b5-1 10,334 $1.25 $12,918 81,439 Direct -11.26% Disposed -25.7% (price as of 2026-10-05)
June 3, 2024 VOR S 10b5-1 14,645 $1.39 $20,357 96,063 Direct -13.23% Disposed -33.2% (price as of 2026-10-05)
Feb. 28, 2022 APRE S 10b5-1 36,000 $1.73 $62,280 47,000 Direct -43.37% Disposed -98.0% (price as of 2026-10-05)
Sept. 16, 2021 APRE S 10b5-1 15,968 $4.68 $74,730 83,000 Direct -16.13% Disposed -99.3% (price as of 2026-10-05)
Oct. 7, 2019 APRE P 200 $15.00 $3,000 200 Indirect · Acquired -99.8% (price as of 2026-10-05)
Oct. 7, 2019 APRE P 200 $15.00 $3,000 200 Indirect · Acquired -99.8% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (364,000) $3.77 Oct. 10, 2032 364,000 Disposed
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (364,000) · Oct. 10, 2032 364,000 Acquired
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (109,000) $5.55 Feb. 5, 2033 109,000 Disposed
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (109,000) · Feb. 5, 2033 109,000 Acquired
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (125,000) $2.41 Jan. 28, 2034 125,000 Disposed
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (125,000) · Jan. 28, 2034 125,000 Acquired
Feb. 3, 2025 VOR Employee Stock Option (right to buy) Common Stock (315,000) $1.34 Feb. 2, 2035 315,000 Acquired
Jan. 29, 2024 VOR Employee Stock Option (right to buy) Common Stock (125,000) $2.41 Jan. 28, 2034 125,000 Acquired
Feb. 6, 2023 VOR Employee Stock Option (right to buy) Common Stock (109,000) $5.55 Feb. 5, 2033 109,000 Acquired
Oct. 11, 2022 VOR Employee Stock Option (right to buy) Common Stock (364,000) $3.77 Oct. 10, 2032 364,000 Acquired
March 10, 2022 APRE Stock Option (right to Buy) Common Stock (185,900) $1.82 March 10, 2032 185,900 Acquired
Feb. 25, 2021 APRE Stock Option (right to Buy) Common Stock (143,000) $6.00 Feb. 25, 2031 143,000 Acquired
March 24, 2020 APRE Stock Option (right to Buy) Common Stock (55,000) $35.50 March 24, 2030 55,000 Acquired
Oct. 7, 2019 APRE Stock Option (right to Buy) Common Stock (77,630) $15.00 Oct. 2, 2029 77,630 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 2, 2019 APRE Stock Option (right to buy)→ Common Stock (262,736) 262,736 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2019 $301,250 · · $766,208 $121,825 · · $1,189,283

VOR

M.D.(7) Former Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2024 $487,100 · $150,625 $230,000 $195,303 · $12,757 $1,075,785
2023 $474,000 · · · $180,286 · $6,269 $1,400,120

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.